ASTRAZENECA PHARMACEUTICALS LP for ASTRAZENECA PHARMACEUTICALS LP
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
H.R. 3309, S 1720, S 1013, S 1612 - patent litigation reform
| Lobbyist | Covered position, as disclosed |
|---|---|
| THERESA JOLIVETTE | — |
| JACQUELINE POMFRET KIRBY | — |
| BELA SASTRY | — |
Trade (domestic/foreign) TRD
Intellectual property and market access issues in various European and Asian countries
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRADLEY ALLEN ROSSIN | — |
Taxation/Internal Revenue Code TAX
Reform of tax code and possible timing of any such reform bill (no bill number yet)
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRADLEY ALLEN ROSSIN | — |
Health Issues HCR
Oversight and possible amendment or reform of federal 340B pharmaceutical purchasing program H.R. 3742 - Legislative proposals regarding the development and reimbursement of antibiotics Infant repiratory health issues - no legislation assigned
| Lobbyist | Covered position, as disclosed |
|---|---|
| THERESA JOLIVETTE | — |
| JACQUELINE POMFRET KIRBY | — |
| JOHN MYERS | Sr. Health & Sci. Adv. Sen. Spector (2008-10) |
| BELA SASTRY | — |
Medicare/Medicaid MMM
H.R. 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) - Medicare and Medicaid reform including issues related to low income beneficiaries and protected medication classes
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARIA FIRVIDA New | — |
| THERESA JOLIVETTE | — |
| JACQUELINE POMFRET KIRBY | — |
| BELA SASTRY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.